Inventor
COLSON PIERRE-JEAN
US36 patents
⚠️ This page may combine multiple inventors who share the name “COLSON PIERRE-JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
COLSON PIERRE-JEAN
8 patentsUS8754225B2Jun 17, 2014
Process for preparing a biphenyl-2-ylcarbamic acid
COLSON PIERRE-JEAN20 citations92
US8134006B2Mar 13, 2012
Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
COLSON PIERRE-JEAN15 citations92
US9035061B2May 19, 2015
Process for preparing a biphenyl-2-ylcarbamic acid
COLSON PIERRE-JEAN6 citations84
US8247559B2Aug 21, 2012
Process for preparing an intermediate to mu opioid receptor antagonists
COLSON PIERRE-JEAN8 citations83
US8476440B2Jul 2, 2013
Process for preparing an intermediate to mu opioid receptor antagonists
COLSON PIERRE-JEAN3 citations62
US9221763B2Dec 29, 2015
Process for preparing biphenyl imidazole compounds
COLSON PIERRE-JEAN0 citations52
US8969403B2Mar 3, 2015
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
COLSON PIERRE-JEAN0 citations46
US8658691B2Feb 25, 2014
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
COLSON PIERRE-JEAN0 citations46
THERAVANCE INC
6 patentsUS7524965B2Apr 28, 2009
Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC44 citations96
US7687521B2Mar 30, 2010
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC23 citations93
US7943772B2May 17, 2011
Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
THERAVANCE INC24 citations92
US7521558B2Apr 21, 2009
Crystalline form of a biphenyl compound
THERAVANCE INC27 citations92
US7320990B2Jan 22, 2008
Crystalline form of a biphenyl compound
THERAVANCE INC28 citations91
US7932402B2Apr 26, 2011
Process for preparing an intermediate to opioid receptor antagonists
THERAVANCE INC8 citations84
THERAVANCE BIOPHARMA R&D IP LLC
4 patentsUS10844057B2Nov 24, 2020
Process for preparing JAK inhibitors and intermediates thereof
THERAVANCE BIOPHARMA R&D IP LLC11 citations84
US9949963B2Apr 24, 2018
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
THERAVANCE BIOPHARMA R&D IP LLC4 citations83
US10426766B2Oct 1, 2019
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
THERAVANCE BIOPHARMA R&D IP LLC2 citations72
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
CHAO ROBERT S
3 patentsDALZIEL SEAN M
3 patentsUS8536335B2Sep 17, 2013
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
DALZIEL SEAN M14 citations91
US8247555B2Aug 21, 2012
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
DALZIEL SEAN M15 citations91
US9290491B2Mar 22, 2016
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
DALZIEL SEAN M6 citations83
SEARLE & CO
3 patentsZHANG WEIJIANG
3 patentsUS8188294B2May 29, 2012
Process for preparing biphenyl imidazole compounds
ZHANG WEIJIANG3 citations62
US8889882B2Nov 18, 2014
Process for preparing biphenyl imidazole compounds
ZHANG WEIJIANG0 citations51
US8541597B2Sep 24, 2013
Process for preparing biphenyl imidazole compounds
ZHANG WEIJIANG0 citations51